| Literature DB >> 31683872 |
Chie Omori1,2,3, Daisuke Ekuni4, Yumiko Ohbayashi5, Minoru Miyake6, Manabu Morita7.
Abstract
The assessor-blinded, parallel-design, quasi-randomized study (alternating allocation) aimed to determine the effects of the six-step method on postoperative numbers of oral bacteria, periodontal status, and atrial fibrillation (AF) among inpatients with heart diseases and periodontitis. Seventy inpatients who received preoperative periodontal treatment were quasi-randomly assigned to intervention and control groups at University Hospital. The intervention group received intensive oral hygiene instruction using a six-step method for 15 minutes per week and the control group received routine oral hygiene instruction. Significantly fewer oral bacteria were identified on the tongue at discharge compared with baseline in the intervention than the control group (ANCOVA) (large effect size, p = 0.02). Changes in scores for self-efficacy, plaque scores, probed pocket depth, and bleeding on probing between baseline and discharge were significantly greater in the intervention, than in the control group (p < 0.05). The period of postoperative AF (days) was significantly shorter in the intervention, than in the control group (p = 0.019). In conclusion, oral hygiene instruction using the six-step method decreased the numbers of oral bacteria on the tongue and improved self-efficacy, oral health behaviors, oral hygiene status, periodontal status, and period of postoperative AF among inpatients with periodontitis and heart diseases.Entities:
Keywords: oral hygiene instruction; perioperative period; self-efficacy; six-step method
Mesh:
Year: 2019 PMID: 31683872 PMCID: PMC6862145 DOI: 10.3390/ijerph16214252
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Typical oral hygiene instruction in the control and intervention groups.
| Control | Intervention | |
|---|---|---|
| Priority | Teaching skills | Counseling |
| Disclosing dental plaque accumulation | + | + |
| Technical guidance of brushing | Teaching how to use interdental brushes | Teaching how to use interdental brushes |
| Six-step method | − | Asking the reason why a patient did not use interdental brushes and getting the patient to identify the problem |
| STEP1: | ||
| Identification of the problem in each patient | ||
| STEP2: | − | Counseling the patient to use interdental brushes |
| Creation of commitment and confidence | ||
| STEP3: | − | Instructing the patients to maintain the use of interdental brushes by self-monitoring |
| Increase awareness of behavior | ||
| STEP4: | − | Setting an achievable plan, "use interdental brushes daily," for the patient |
| Development and implementation of an action plan | ||
| STEP5: | − | Praising improvements in the oral hygiene status after the patient used interdental brushes daily |
| Evaluation of the plan | ||
| STEP6: | − | Reinforcing the daily use of interdental brushes and encouraging the patient |
| Maintenance of change and prevention of relapse |
Figure 1Flowchart of the study.
Baseline characteristics of participants.
| Parameter | Control (N = 35) | Intervention (N = 35) |
|---|---|---|
| Male | 24 (68.6) * | 24 (68.6) |
| Age (y) | 70.9 ± 11.1 | 68.1 ± 11.4 |
| BMI (kg/m2) | 22.0 ± 4.1 | 22.5 ± 4.0 |
| Habit | ||
| Cigarette smoking | 26 (74.3) | 23 (65.7) |
| Alcohol consumption | 13 (37.1) | 15 (42.9) |
| Systemic conditions | ||
| Primary heart disease | ||
| Nonrheumatic mitral valve disorders | 7 (20.0) | 9 (25.7) |
| Nonrheumatic aortic valve disorders | 5 (14.3) | 7 (20.0) |
| Chronic ischemic heart disease | 6 (17.1) | 6 (17.1) |
| Atherosclerosis | 8 (22.9) | 4 (11.4) |
| Aortic aneurysm and dissection | 2 (5.7) | 5 (14.3) |
| Angina pectoris | 3 (8.6) | 2 (5.7) |
| Multiple valve diseases | 3 (8.6) | 1 (2.9) |
| Complications and vague descriptions of heart disease | 1 (2.9) | 0 (0.0) |
| Infection following procedure, not elsewhere classified | 0 (0.0) | 1 (2.9) |
| Other heart diseases | 14 (40.0) | 11 (31.4) |
| Medical history except for heart diseases (>2) | 12 (34.3) | 11 (31.4) |
| Medications for heart diseases) (>2) | 27(77.1) | 20 (57.1) |
| Medications for other diseases) (>2) | 20 (57.1) | 18 (51.4) |
| Type of surgery | ||
| Aortic valve replacement | 11 (31.4) | 6 (17.1) |
| Cardiac valve annuloplasty | 6 (17.1) | 8 (22.9) |
| Vascular replacement | 2 (5.71) | 8 (22.9) |
| Bypass | 16 (45.7) | 12 (34.3) |
| Debridement | 0 (0.0) | 1 (2.9) |
| Oral status | ||
| Number of teeth | 16.8 ± 8.8 | 19.4 ± 8.8 |
| DMFT | 18.7 ± 7.7 | 17.9 ± 7.8 |
| Periodontal status | ||
| Mean PPD (mm) | 4.5 ± 1.0 | 4.3 ± 1.0 |
| PPD ≥4 mm (%) | 76.4 ± 22.8 | 69.3 ± 23.6 |
| Periodontitis severity | ||
| Severe | 32 (91.4) | 32 (91.4) |
| Moderate | 3 (8.6) | 3 (8.6) |
| BOP (%) | 70.6 ± 19.5 | 63.7 ± 21.2 |
| PCR (%) | 72.8 ± 17.5 | 73.3 ± 17.6 |
| Tongue status | ||
| Tongue coating score | 1.1 ± 0.9 | 1.5 ± 1.0 |
| Numbers of oral bacteria on tongue (×107; cfu/mL) | 3.8 ± 2.8 | 3.6 ± 2.8 |
| SESS score | 55.5 ± 13.3 | 54.6 ± 10.2 |
* Data are shown as means ± SD or N (%). BOP, bleeding on probing; DMFT, decayed missing and filled teeth; PCR, plaque control record; PPD, probed pocket depth; SESS, self-efficacy scale for self-care.
Differences in postoperative conditions between control and intervention groups.
| Parameter | Control | Intervention |
|
|---|---|---|---|
| Surgical factors | |||
| Duration (min) | 344 ± 162 * | 347 ± 143 | 0.934 |
| Blood loss (mL) | 1208 ± 1518 | 1321 ± 1584 | 0.763 |
| Duration of stays (days) | |||
| Hospital | 27.5 ± 14.0 | 29.5 ± 14.2 | 0.554 |
| ICU | 3.4 ± 3.3 | 3.1 ± 1.9 | 0.569 |
| CCU | 5.4 ± 5.8 | 3.6 ± 2.4 | 0.099 |
| Medications | |||
| Postoperative medications (>2) | 33 (94.3) | 30 (85.7) | 0.615 |
| Duration of antibiotics (days) | 5.7 ± 7.2 | 4.5 ± 3.8 | 0.386 |
| Acetaminophen (×102 mg) | 0.8 ± 1.1 | 0.8 ± 1.3 | 0.918 |
| Flurbiprofen (mg) | 0.3 ± 0.6 | 0.1 ± 0.4 | 0.166 |
| Fentanyl (mg) | 25.1 ± 12.3 | 28.7 ± 11.4 | 0.214 |
| Remifentanil hydrochloride (mg) | 2.8 ± 2.0 | 3.5 ± 2.0 | 0.152 |
| PCA (mL) | 8.9 ± 15.8 | 8.5 ± 13.3 | 0.908 |
| Intubation period (days) | 0.7 ± 2.0 | 0.5 ± 1.5 | 0.741 |
| Postoperative duration to ingestion (days) | 2.1 ± 3.4 | 2.4 ± 5.1 | 0.804 |
| Number of days with fever ≥38.0 °C within one week | 2.9 ± 2.9 | 2.1 ± 2.0 | 0.168 |
| Blood test findings | |||
| CRP POD 1 (mg/dL) | 4.0 ± 3.0 | 3.8 ± 2.3 | 0.765 |
| CRP POD 3 (mg/dL) | 11.1 ± 6.8 | 11.1 ± 5.2 | 0.995 |
| CRP POD 7 (mg/dL) | 4.7 ± 2.7 | 4.7 ± 3.5 | 0.966 |
| WBC POD 1 (×102/μL) | 94.1 ± 28.3 | 101.6 ± 26.0 | 0.248 |
| WBC POD 3 (×102/μL) | 97.2 ± 37.4 | 142.4 ± 248.1 | 0.29 |
| WBC POD 7 (×102/μL) | 77.6 ± 26.7 | 79.7 ± 23.4 | 0.716 |
| Events | |||
| Atelectasis | 23 (65.7) † | 17 (48.6) | 0.147 |
| Postoperative pain | 26 (74.3) | 26 (74.3) | 1 |
| Pneumonia | 4 (11.4) | 1 (2.9) | 0.164 |
| Postoperative infection | 6 (17.1) | 4 (11.4) | 0.495 |
| Delirium | 3 (8.6) | 1 (2.9) | 0.303 |
| AF (day) | 4.8 ± 7.6 | 1.5 ± 2.8 | 0.019 |
| AF incidence (%) | 19 (54.3) | 12 (34.3) | 0.092 |
| Readmission | 7 (20.0) | 5 (14.3) | 0.526 |
* Data are shown as means ± SD or n (%). † Chi-squared or t-tests. AF, atrial fibrillation; CCU, coronary care unit; CRP, C-reactive protein; ICU, intensive care unit; PCA, patient controlled analgesia; POD, postoperative day; WBC, white blood cell count.
Differences in oral status, self-efficacy scale for self-care and atrial fibrillation between control and intervention groups.
| Parameter | Control | Intervention | Adjusted Difference †
|
| Effect Size § |
|---|---|---|---|---|---|
|
| |||||
| PCR (%) | 73.0 ± 22.5* | 50.7 ± 19.4 | −19.6 (−27.9 to −11.3) | <0.001 | 1.06 |
| Tongue coating score | 1.4 ± 1.0 | 1.6 ± 1.0 | −0.1 (−0.7 to 0.3) | 0.434 | 0.2 |
| Numbers of oral bacteria on tongue (×107) (cfu/mL) | 2.4 ± 2.4 | 2.0 ± 1.7 | −0.3 (−2.0 to 1.3) | 0.71 | 0.19 |
|
| |||||
| PCR (%) | 63.5 ± 24.9 | 39.2 ± 22.1 | −21.8 (−31.0 to −12.7) | <0.001 | 1.03 |
| Tongue coating score | 1.3 ± 1.0 | 0.7 ± 0.9 | −1.1 (−1.6 to −0.5) | <0.001 | 0.63 |
|
| |||||
| Mean PPD (mm) | 4.1 ± 0.9 | 3.6 ± 0.7 | −0.3 (−0.5 to −0.1) | 0.005 | 0.62 |
| PPD ≥4 mm (%) | 61.4 ± 26.8 | 39.4 ± 26.7 | −14.4 (−21.9 to −6.9) | <0.001 | 1.16 |
| BOP (%) | 47.1 ± 22.6 | 27.6 ± 15.6 | −11.4 (−19.0 to −3.90) | 0.004 | 1.00 |
| PCR (%) | 62.5 ± 22.8 | 28.7 ± 16.9 | −31.2 (−39.9 to −22.6) | <0.001 | 1.68 |
| Tongue coating score | 1.1 ± 1.0 | 0.3 ± 0.5 | −1.2 (−1.7 to −0.6) | 0.001 | 1.01 |
| Numbers of oral bacteria on tongue (×107) (cfu/mL) | 3.0 ± 2.1 | 1.1 ± 0.9 | −1.7 (−3.2 to −0.3) | 0.02 | 1.18 |
| SESS scores | 52.7 ± 9.9 | 60.6 ± 10.1 | 8.7 (3.6 to 13.8) | 0.001 | 0.99 |
| AF (days) | 4.8 ± 7.6 | 1.5 ± 2.5 | −3.5 (−5.6 to −0.6) | 0.019 | 0.58 |
* Means ± SD. †Adjusted for surgical duration and type of surgery. ‡ Changes in parameters between control and intervention groups based on t-tests after ANCOVA. § Cohen’s d. The small, medium and large effect sizes are d = 0.20, 0.50 and 0.80, respectively. AF, atrial fibrillation; BOP, bleeding on probing; CI, Confidence interval; PCR, plaque control record; PPD, probing pocket depth; SESS, self-efficacy scale for self-care.